Sign in

CIK 0001640266

  • Accelerated filer
  • Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-03-23 Henderson Jane Sr. V.P. & CFO, Corp. Dev. Sale −11,200 $20.52 $230K 0
2018-03-23 Henderson Jane Sr. V.P. & CFO, Corp. Dev. Exercise or conversion · Stock Option (Right to Buy) −11,200 165,584
2018-03-22 Henderson Jane Sr. V.P. & CFO, Corp. Dev. Exercise or conversion +19,900 $11.97 $238K 19,900
2018-03-22 Henderson Jane Sr. V.P. & CFO, Corp. Dev. Sale −19,900 $21.07 $419K 0
2018-03-22 Henderson Jane Sr. V.P. & CFO, Corp. Dev. Exercise or conversion · Stock Option (Right to Buy) −19,900 176,784
2018-03-19 Henderson Jane CFO & SVP, Corp. Dev. Exercise or conversion +1,900 $11.97 $23K 1,900
2018-03-19 Henderson Jane CFO & SVP, Corp. Dev. Sale −1,900 $21.76 $41K 0
2018-03-19 Henderson Jane CFO & SVP, Corp. Dev. Exercise or conversion · Stock Option (Right to Buy) −1,900 196,684
2018-03-16 Henderson Jane CFO & SVP, Corp. Dev. Exercise or conversion +15,416 $11.97 $185K 15,416
2018-03-16 Henderson Jane CFO & SVP, Corp. Dev. Sale −15,416 $22.15 $341K 0
2018-03-16 Henderson Jane CFO & SVP, Corp. Dev. Exercise or conversion · Stock Option (Right to Buy) −15,416 198,584
2018-03-12 Ravina Bernard Chief Medical Officer Sale −2,451 $25.16 $62K 2,451
2018-03-07 PAUL STEVEN M Chief Executive Officer Grant or award · Stock Option (Right to Buy) +110,000 110,000
2018-03-07 Ottmer Matthew P. Chief Operating Officer Grant or award · Stock Option (Right to Buy) +65,000 65,000
2018-03-07 Sah Dinah Ph.D. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +65,000 65,000
2018-03-07 Ravina Bernard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +65,000 65,000
2018-03-07 Henderson Jane Sr. V.P. & CFO Grant or award · Stock Option (Right to Buy) +65,000 65,000
2018-02-27 Sah Dinah Ph.D. Chief Scientific Officer Exercise or conversion −2,184 $7.27 $16K 140,872
2018-02-27 Sah Dinah Ph.D. Chief Scientific Officer Exercise or conversion −4,376 $8.33 $36K 145,248
2018-02-27 Sah Dinah Ph.D. Chief Scientific Officer Exercise or conversion −5,000 $11.09 $55K 150,248

Page 16 of 19 · 368 trades